Damras Tresukosol | Her Majesty's Cardiac Center, Siriraj Hospital
スポンサーリンク
概要
関連著者
-
Nakamura Sunao
Department of Cardiology, New Tokyo Hospital
-
Wasan Udayachalerm
King Chulalongkorn Memorial Hospital
-
Damras Tresukosol
Her Majesty's Cardiac Center, Siriraj Hospital
-
Sudaratana Tansuphaswadikul
Chest Disease Institute
-
Bae Jang-Ho
Konyang University Hospital
-
Nakamura Shotaro
Secomedic Hospital
-
Udayachalerm Wasan
King Chulalongkorn Memorial Hospital
-
Tansuphaswadikul Sudaratana
Chest Disease Institute
-
Nakamura Sunao
Department Of Cardiology New Tokyo Hospital
-
Tresukosol Damras
Her Majesty's Cardiac Center Siriraj Hospital
-
Damras Tresukosol
Her Majesty's Cardiac Center Siriraj Hospital
-
Ogawa Hisao
Department Of Cardiology Kumamoto University
-
Jang-Ho Bae
Konyang University Hospital
-
Ogawa Hisao
Kumamoto University Hospital
-
Ogawa Hisao
Kumamoto University
-
Hans Cahyadi
Husada Hospital
-
Hans Yeo
Husada Hospital
-
Cahyadi Yeo
Husada Hospital
-
Cahyadi Yeohans
Husada Hospital
-
Cahyadi Yeo
Department Of Cardiology Husada Hospital
-
Ogawa Hisao
Department of Cardiology, Kumamoto University
-
Nakamura Sunao
New Tokyo Hospital
-
Nakamura Shotaro
Department of Cardiology, New Tokyo Hospital
-
Nakamura Shotaro
Department Of Applied Chemistry Faculty Of Engineering
-
Yeo Hans
Husada Hospital
-
Yeo H.
Husada Hospital
-
YeoHans Cahyadi
Husada Hospital
-
Ogawa Hisao
Department Cardiovascular Medicine Kumamoto University:division Of Intensive Care Unit Kumamoto Univ
-
Nakamura Sunao
Cardiovascular Center, New Tokyo Hospital
-
Nakamura Sunao
Cardiovascular Center New Tokyo Hospital
著作論文
- PJ-123 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Diffuse In-Stent Restenosis : Multicenter Registry in Asia(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japanese),The 73rd Annual Scienti
- PJ-122 Drug-Eluting Stents for the Treatment of CTO : A Comparison with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent: Multicenter Registry(PJ021,Coronary Revascularization, PCI (Complex Lesions) (IHD),Poster Session (Japane
- OJ-125 Rotational Atherectomy Prior to the Stenting with Sirolimus-Eluting Stent for Long Coronary Lesions : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientifi
- OJ-124 Comparison of 4Years Efficacy and Durability of DES Implantation in Non-bifurcation and Bifurcation Lesion of Unprotected LMT : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese),The 73r
- OJ-123 Systematic Double Stenting versus Simple Provisional T-stenting for True Bifurcation Lesions of LMT Disease Using Drug Eluting Stents : Multicenter Registry(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese)
- OJ-122 Impact of Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent on the Outcome of Patients with Sirolimus-Eluting Stent Failure : Multicenter Registry in Asia(OJ21,Coronary Revascularization, PCI (Complex Lesions) 2 (IHD),Oral Presentation (Japanese
- OJ-039 Drug-Eluting Stents for the Treatment of Left Main Coronary Artery Disease with Sirolimus, Paclitaxel, Zotarolimus, EPC Capture and Everolimus-Eluting Stent(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese)
- OJ-038 Comparison of 4 Years Efficacy and Durability of SES and PES Deployment in Patients with Very Long Coronary Lesions(OJ07,Coronary Revascularization, PCI (Complex Lesions) 1 (IHD),Oral Presentation (Japanese),The 73rd Annual Scientific Meeting of Th
- 1 Low Incidence of Stent Thrombosis in Asian Races : Multicenter Registry in Asia 3 Years Follow-Up Result(Current Status and Future Perspective of Drug-Eluting Stents,Plenary Session 1 (PL-1) (A),The 73rd Annual Scientific Meeting of The Japanese Circula
- 4 Comparison of Efficacy and Durability between Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent in Unprotected Left Main Coronary Arteries(Plenary Session 1 (PL-1) (IHD) Drug-Eluting Stents : Long-Term Effects and Emerging Problems,Special Program,Th